Timothy E Morris's Net Worth

$6.28 Million

Estimate Recalculated Nov 1, 2024 09:17AM EST

Who is Timothy E Morris

Timothy E Morris has an estimated net worth of $6.28 Million. This is based on reported shares across multiple companies, which include IOVANCE BIOTHERAPEUTICS, INC., DBV Technologies S.A., KALOBIOS PHARMACEUTICALS INC, ACELRX PHARMACEUTICALS INC, Aquestive Therapeutics, Inc., QUESTCOR PHARMACEUTICALS INC, and VIVUS INC.

SEC CIK

Timothy E Morris's CIK is 0001191286

Past Insider Trading and Trends

2012 was Timothy E Morris's most active year for acquiring shares with 13 total transactions. Timothy E Morris's most active month to acquire stocks was the month of December. 2012 was Timothy E Morris's most active year for disposing of shares, totalling 22 transactions. Timothy E Morris's most active month to dispose stocks was the month of January. 2012 saw Timothy E Morris paying a total of $1,788,585.70 for 444,358 shares, this is the most they've acquired in one year. In 2012 Timothy E Morris cashed out on 708,716 shares for a total of $7,761,417.02, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IOVANCE BIOTHERAPEUTICS, INC.

Chief Financial Officer
Updated Mar 06, 2019
Form 4
100.00K
Mar 06, 2019
100.00K
Grant
Mar 04
Form 4
250.00K
Aug 16, 2017
250.00K
Grant
Aug 14
Form 3
Aug 16, 2017
Showing 3 results

DBV Technologies S.A.

Investor
Updated Aug 28, 2023
Form 4
12.00K
$1.52
$18.24K
Aug 28, 2023
12.00K
Purchase
Aug 25
Form 4
6.84K
$7.12
$48.68K
Jun 11, 2021
6.84K
Purchase
Jun 10
Form 3
Apr 02, 2021
Showing 3 results

KALOBIOS PHARMACEUTICALS INC

COO and CFO
Updated Jul 29, 2022
Form 4
600.36K
Jul 29, 2022
600.36K
Grant
Jul 27
Form 4
59.84K
Jan 14, 2022
59.84K
Grant
Jan 12
Form 4
51.00K
Jan 04, 2022
51.00K
Grant
Dec 31
Form 4
151.32K
Sep 22, 2020
151.32K
Grant
Sep 18
Form 4
804.11K
Mar 13, 2018
804.11K
Grant
Mar 09
Form 4
100.00K
Sep 15, 2016
100.00K
Grant
Sep 13
Form 3
Jul 11, 2016
Showing 7 results

ACELRX PHARMACEUTICALS INC

Chief Financial Officer
Updated Feb 09, 2017
Form 4
112.50K
Feb 09, 2017
112.50K
Grant
Feb 07
Form 4
110.50K
Feb 18, 2016
110.50K
Grant
Feb 10
Form 4
100.00K
May 01, 2015
100.00K
Grant
Apr 29
Form 4
100.00K
Dec 04, 2014
100.00K
Grant
Dec 02
Form 4
200.00K
May 08, 2014
200.00K
Grant
May 07
Form 3
Apr 09, 2014
Showing 6 results

Aquestive Therapeutics, Inc.

Investor
Updated Jun 21, 2024
Form 4
38.00K
Jun 21, 2024
38.00K
Grant
Jun 20
Form 4
25.00K
Jun 23, 2023
25.00K
Grant
Jun 21
Form 4
28.50K
Aug 17, 2022
28.50K
Grant
Aug 16
Showing 3 results

QUESTCOR PHARMACEUTICALS INC

Sr. VP, Finance & Admin, CFO
Updated Sep 07, 2004
Form 4
19.20K
$0.40
$7.68K
Sep 07, 2004
19.20K
Purchase
Sep 03
Showing 1 results

VIVUS INC

VP, Finance and CFO
Updated Sep 09, 2013
Form 4
-8.41%
-10.65K
$8.09
-$82.22K
Sep 09, 2013
116.01K
Sale
Sep 05
Form 4
110.00K
Jan 29, 2013
110.00K
Grant
Jan 25
Form 4
-16.48%
-25.00K
$17.30
-$653.25K
Jul 20, 2012
126.66K
Sale
ScheduledJul 18
Form 4
-68.47%
-329.36K
$13.19
-$5.32M
Feb 27, 2012
151.66K
Sale
ScheduledFeb 23 - Feb 27
Form 4
90.00K
Jan 31, 2012
90.00K
Grant
Jan 27
Form 4
80.00K
Jan 25, 2011
80.00K
Grant
Jan 21
Form 4
-100.00%
-26.25K
$7.65
-$237.13K
Jun 16, 2010
Sale
ScheduledJun 14
Form 4
80.00K
Jan 26, 2010
80.00K
Grant
Jan 22
Form 4
200.00K
Jan 27, 2009
200.00K
Grant
Jan 23
Form 4
150.00K
Jan 29, 2008
150.00K
Grant
Jan 25
Form 4
100.00K
Jan 31, 2007
100.00K
Grant
Jan 29
Form 4
26.25K
Jan 31, 2006
26.25K
Grant
Jan 30
Form 4
4.36K
Jan 26, 2005
4.36K
Grant
Jan 24
Form 4
200.00K
Nov 10, 2004
200.00K
Grant
Nov 09
Form 3
Nov 10, 2004
Showing 15 results